Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

May 08, 2017 08:00 ET | Source: CRISPR Therapeutics AG

CRISPR Therapeutics Announces Exclusive License of Lipid Nanoparticle Technologies Developed at MIT

BASEL, Switzerland and CAMBRIDGE, Mass., May 08, 2017 (GLOBE NEWSWIRE) -- CRISPR Therapeutics (NASDAQ:CRSP), a biopharmaceutical company focused on creating transformative gene-based medicines for...
March 30, 2017 08:00 ET | Source: CRISPR Therapeutics AG

CRISPR Therapeutics to Present at the 16th Annual Needham Healthcare Conference

BASEL, Switzerland and CAMBRIDGE, Mass., March 30, 2017 (GLOBE NEWSWIRE) -- CRISPR Therapeutics (NASDAQ:CRSP), a biopharmaceutical company focused on translating CRISPR-Cas9 gene-editing technology...
March 28, 2017 08:00 ET | Source: CRISPR Therapeutics AG

CRISPR Therapeutics Announces European Patent for CRISPR/Cas Gene Editing

- Patent to include CRISPR/Cas9 gene editing compositions for use in any non-cellular and cellular setting, including human and other eukaryotic cells BASEL, Switzerland, March 28, 2017 (GLOBE...
March 14, 2017 07:00 ET | Source: CRISPR Therapeutics AG

CRISPR Therapeutics and Casebia Therapeutics Announce Commercial License Agreement With MaxCyte

BASEL, Switzerland, CAMBRIDGE, Mass., and GAITHERSBURG, Md., March 14, 2017 (GLOBE NEWSWIRE) -- CRISPR Therapeutics (NASDAQ:CRSP), a biopharmaceutical company focused on creating transformative...
March 02, 2017 16:30 ET | Source: CRISPR Therapeutics AG

CRISPR Therapeutics to Present at the Annual Barclays Global Healthcare Conference

BASEL, Switzerland and CAMBRIDGE, Mass., March 02, 2017 (GLOBE NEWSWIRE) -- CRISPR Therapeutics (NASDAQ:CRSP), a biopharmaceutical company focused on translating CRISPR-Cas9 gene-editing technology...